Molecular BiologyPLoS ONEPeer-reviewed
Blockade of Interleukin-6 (IL-6) Signaling in Dedifferentiated Liposarcoma (DDLPS) Decreases Mouse Double Minute 2 (MDM2) Oncogenicity via Alternative Splicing
Abeba Zewdu, Danielle Braggio, Gonzalo Lopez…·Raphael E. Pollock
This study shows that blocking IL-6 signaling in DDLPS reduces MDM2 oncogenicity through alternative splicing, suggesting a potential therapeutic target.
2 citations